Wednesday, July 16, 2014

Top 10 Life Sciences Stocks To Watch For 2014

With shares of Corning (NYSE:GLW) trading around $15, is GLW an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Corning produces and sells specialty glasses, ceramics, and related materials worldwide. It operates through five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences.�Corning launched Corning Lotus Glass, an environmentally friendly display glass for organic LED and LCD displays that are used in portable devices, such as smart phones, tablets, and notebook computers. Smart phones, tablets, and notebook computers and their related materials are seeing explosive growth in developed and developing countries around the world. Companies that provide the products necessary to develop and improve existing technology, like Corning, will see a continued rise in profits as consumers and companies demand products that maximize their efforts.

Hot Services Stocks To Invest In 2015: WPCS International Incorporated(WPCS)

WPCS International Incorporated provides design-build engineering services for communications infrastructure. The company operates in three segments: Electrical Power, Wireless Communication, and Specialty Construction. The Electrical Power segment provides electrical contracting services to help commercial and industrial facilities for upgrading power systems; and creates integrated building systems, including the installation of structured cabling systems and electrical networks, as well as supports the integration of telecommunications, fire protection, security, and HVAC. The Wireless Communication segment designs and deploys wireless network solutions comprising Wi-Fi networks, point-to-point systems, mesh networks, microwave systems, cellular networks, in-building systems, and two-way communication systems. The Specialty Construction segment offers specialty construction services for building design, such as the design and integration of mechanical, electrical, hydra ulic, and life safety systems. The company provides its services to public services, healthcare, energy, and corporate enterprise markets worldwide. WPCS International Incorporated was founded in 1997 and is headquartered in Exton, Pennsylvania.

Advisors' Opinion:
  • [By Wallace Witkowski]

    Shares of WPCS International Inc. (WPCS) �continued trading heavily after the bell Friday, a day when shares shot up nearly 68% to close at $2.53 after the launch of a trading platform for bitcoins. The day�� trading volume topped more than 1.5 million shares, more than triple its average regular session trading volume. Shares were down 3.2% at $2.45 after-hours at last check.

  • [By Barbara Kollmeyer]

    Shares of WPCS International Inc. (WPCS) �were up 40% in thin premarket trading. The company said Thursday that one of its units released a software platform for bitcoin traders.

  • [By Monica Gerson]

    WPCS International (NASDAQ: WPCS) announced the public release of beta version of its Windows-based trading platform for bitcoin traders. WPCS shares jumped 26.49% to $1.91 in the after-hours trading.

  • [By Steven Russolillo]

    WPCS International(WPCS) surged 21% in the extended session late Thursday after the firm said its BTX Trader unit had launched a platform for bitcoin traders.

Top 10 Life Sciences Stocks To Watch For 2014: AZ Electronic Materials SA (AZEM)

AZ Electronic Materials SA is a producer and supplier of specialty chemical materials. AZ operates in four segments: IC Materials, which includes products for use in integrated circuits and devices; Optronics, which includes products used in the production of flat panel displays for use in televisions, computer monitors and similar equipment and light emitting diode technology; Printing and Other, which includes printing and similar products used in photo lithographic processes, and Corporate. The Company�� products enable the manufacture of integrated circuits (ICs) and flat panel displays (FPDs) that are integral to a range of electronic devices and applications, including computers and tablet devices, flat screen televisions, mobile communication devices, industrial and automotive applications and the developing light and energy markets. Advisors' Opinion:
  • [By Corinne Gretler]

    AZ Electronic (AZEM) surged 43 percent, the most since its at least November 2010, after Merck on Dec. 5 said it had agreed to buy the company for about 1.6 billion pounds. Merck added 0.4 percent. Shareholders will get 403.5 pence for each share, Merck said. The price is 53 percent above the Dec. 4 closing level in London trading.

Top 10 Life Sciences Stocks To Watch For 2014: The Medicines Company(MDCO)

The Medicines Company, a pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty and for use in patients undergoing percutaneous coronary intervention; and Cleviprex, an intravenous small molecule calcium channel blocker for the reduction of blood pressure, as well as to treat neurocritical care and cardiac surgery patients. Its products under development include Cangrelor that is in Phase III clinical trial acts as an intravenous small molecule antiplatelet agent to prevent platelet activation and aggregation; and Oritavancin, which is in Phase III clinical trial acts as an investigational intravenous antibiotic for the treatment of serious gram-positive bacterial infections, including acute bacterial skin and skin structure infections. The company?s products under development also comprise MDCO-157, a pre-registration stage product for platelet inhibition in patients suffering from acute coronary syndrome (ACS), and patients experiencing myocardial infarction, stroke, or peripheral arterial disease; MDCO-2010, a small molecule serine protease inhibitor that is in Phase II clinical trial used for the reduction of blood loss during surgery; and MDCO-216, which is in Phase I clinical trial used for the reversal of atherosclerotic plaque development and the reduction of the risk of coronary events in patients with ACS. Its products also consist of Argatroban, a direct thrombin inhibitor used as anticoagulant for prophylaxis or for the treatment of thrombosis; and acute care generic products. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Equities Trading DOWN
    Shares of The Medicines Company (NASDAQ: MDCO) were down 15.34 percent to $24.06 after the company provided an update on Angiomax patent litigation.

  • [By Jake L'Ecuyer]

    The Medicines Company (NASDAQ: MDCO) was down as well, falling 5.52 percent to $32.33 ahead of the review of its blood clot drug.

    Commodities
    In commodity news, oil traded up 0.23 percent to $100.11, while gold traded up 0.92 percent to $1,274.50.

  • [By Rich Duprey]

    If all goes well in phase 3�trials for�ProFibrix's lead biologic, Fibrocaps -- a treatment�to stop bleeding during surgery -- shareholders of the Netherlands-based drugmaker could receive a hefty payday from The Medicines Company (NASDAQ: MDCO  ) , which says it's willing to buy out the company if it can expect to bring the therapy to market here at home as well as in Europe.

Top 10 Life Sciences Stocks To Watch For 2014: Evertec Inc (EVTC)

EVERTEC, Inc. (EVERTEC), formerly Carib Latam Holdings, Inc., incorporated on January 26, 1989, is a full service transaction processing business in Latin America and the Caribbean. The Company provides a range of merchant acquiring, payment processing and business process management services across 19 countries in the region. It processes over 1.8 billion transactions annually, and manages the electronic payment network for over 4,100 automated teller machines (ATM) and over 104,000 point-of-sale payment terminals. It is the merchant acquirer in the Caribbean and Central America and in Latin America. The Company owns and operates the ATH network, one of ATM and personal identification number debit networks in Latin America. In addition, it provides a suite of services for core bank processing, cash processing and technology outsourcing. It serves a diversified customer base of financial institutions, merchants, corporations and government agencies with technology solutions.

The Company serves a diversified customer base of financial institutions, merchants, corporations and government agencies with technology solutions that are essential to their operations, enabling them to issue, process and accept transactions securely. The Company�� broad suite of services span the entire transaction processing value chain and include a range of front-end customer facing solutions as well as back-end support services. These include: merchant acquiring services, which enable POS and e-commerce merchants to accept and process electronic methods of payment such as debit, credit, prepaid and electronic benefits transfer (EBT) cards; payment processing services, which enable financial institutions and other issuers to manage, support and facilitate the processing for credit, debit, prepaid, ATM and EBT card programs; and business process management solutions, which provide mission critical technology solutions such as core bank processing, as well as information technology (IT) outsourcing and cash mana! gement services to financial institutions, enterprises and governments. The Company offers its customers end-to-end products and solutions across the transaction processing value chain from a single source across numerous channels and geographic markets.

Merchant Acquiring

Merchant Acquiring business provides services to merchants at over 25,000 locations that allow them to accept electronic methods of payment such as debit, credit, prepaid and EBT cards carrying the ATH, Visa, MasterCard, Discover and American Express brands. Its suite of merchant acquiring services includes, but is not limited to, the underwriting of each merchant�� contract, the deployment of POS devices and other equipment necessary to capture merchant transactions, the processing of transactions at the point-of-sale, the settlement of funds with the participating financial institution, detailed sales reports and customer support. The Company�� Merchant Acquiring business generated 20.4%, of total revenues and 26.6%, of total segment income from operations for the year ended December 31, 2012.

Payment Processing

It provide diversified suite of payment processing products and services to blue chip regional and global corporate customers, government agencies, and financial institutions across Latin American and the Caribbean. These services provide the infrastructure technology necessary to facilitate the processing and routing of payments across the transaction processing value chain. At the point-of-sale, it sell transaction processing technology, similar to the services in its Merchant Acquiring business, to other merchant acquirers to enable them to service their its merchant customers. It also offer terminal driving solutions to merchants, merchant acquirers (including its Merchant Acquiring business) and financial institutions, which provide the technology to securely operate, manage and monitor POS terminals and ATMs. It also sells and rent POS devices to financial insti! tution cu! stomers who seek to deploy them across their own businesses. As of December 31, 2012, the Company provides technology services for over 4,100 ATMs and over 104,000 POS terminals in the region and is continuously certifying new machines and devices to expand this reach. The Company�� Payment Processing business accounted for 27.7%, of total revenues and of total segment income from operations for the year ended December 31, 2012.

Business Solutions

The Company provides its financial institution, corporate and government customers with a full suite of business process management solutions including specifically core bank processing, network hosting and management, IT consulting services, business process outsourcing, item and cash processing, and fulfillment. The Company�� Business Solutions business accounted for 51.9%, of total revenues and 31.3%, of total segment income from operations for the year ended December 31, 2012.

The Company Competes with Vantiv, Inc., First Data Corporation, Global Payment Inc., Elavon, Inc., Sage Payment Solutions, Fidelity National Information Services, Inc., Fiserv, Inc. and Total System Services, Inc.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Shares of EVERTEC (NYSE: EVTC) got a boost, shooting up 8.91 percent to $22.99 after the company reported the commencement of offering by selling holders.

Top 10 Life Sciences Stocks To Watch For 2014: Wright Medical Group Inc.(WMGI)

Wright Medical Group, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of devices and biologic products for the extremity, hip, and knee repair and reconstruction. The company also provides surgical solutions for the foot and ankle market. The reconstructive devices are used to replace knee, hip, and other joints and bones that are deteriorated or damaged through disease or injury; and biologics are used to replace damaged or diseased bone to stimulate bone growth and to provide other biological solutions for surgeons and their patients. Wright Medical Group, Inc. offers products in the extremity reconstruction, biologics, knee reconstruction, and hip reconstruction market sectors. It sells its products primarily through a network of employee sales representatives and independent sales representatives in the United States, as well as through a combination of employee sales representatives, independent sales representatives, and stocking distributors in Europe, the Middle East, Africa, Latin America, Asia, Australia, and Canada. The company was founded in 1950 and is headquartered in Arlington, Tennessee.

Advisors' Opinion:
  • [By Seth Jayson]

    Basic guidelines
    In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Wright Medical Group (Nasdaq: WMGI  ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Wright Medical Group doing by this quick checkup? At first glance, pretty well. Trailing-12-month revenue decreased 5.3%, and inventory decreased 10.1%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue shrank 5.0%, and inventory shrank 10.1%. Over the sequential quarterly period, the trend looks OK but not great. Revenue dropped 2.5%, and inventory grew 0.4%.

Top 10 Life Sciences Stocks To Watch For 2014: Lantrovision(s)

Lantrovision (S) Ltd engages in the design, installation, supply, and provision of consultancy services on network integration and structured cabling. It is involved in the design and installation of computer cabling, as well as the trade of related accessories and peripherals; provision of cabling infrastructure services; sale of cabling accessories; and provision of system integration and network infrastructure services, as well as offers installation, maintenance, and support services for structured cabling systems and components. The company also engages in the structure, design, installation, and consultation of network system with computer communication technology. In addition, it manufactures and sells structuralized cable laying system and multimedia technology; trades in computer peripherals, electronic components, and products for various applications, planners, consultants, advisors, and managers in relation to computer services; and supplies data backup and ret rieval systems. Further, the company provides solutions for testing, monitoring, and analyzing enterprise and telecommunication networks; and contracting services for voice, data, and telecommunication. It primarily operates in Singapore, Malaysia, Hong Kong, China, and Korea, as well as in Thailand and the Philippines. The company was founded in 1990 and is based in Singapore.

Advisors' Opinion:
  • [By Live Investor]

    There�� been lot of talks about a possible Sprint (S) and T-Mobile (TMUS) merger. Where�� the relation between the two U.S. telecom giants headed remains a question. Would they continue to be compatriots or join forces together to make a new third entity in the wireless arena? Softbank CEO Masayoshi Son has been quite keen on T-Mobile.

  • [By Alyce Lomax]

    Skoll Foundation's President and CEO Sally Osberg referenced Drucker's quote above while chatting to Sprint (NYSE: S  ) CEO Dan Hesse about the wireless industry and its role in the future, particularly in sustainability.

  • [By Evan Niu, CFA]

    Sprint Nextel's (NYSE: S  ) prepaid Virgin Mobile subsidiary does the same thing. Virgin Mobile doesn't currently offer the newest iPhone 5, but pricing for the older iPhone 4 and iPhone 4S models implies a $100 promotional subsidy, again for a carrier with no contracts. Unlike Leap, Sprint actually appears to be ahead of schedule with its own iPhone obligations.

Top 10 Life Sciences Stocks To Watch For 2014: Chimera Investment Corporation (CIM)

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and other asset classes. Its targeted asset classes include agency or non-agency RMBS; prime, jumbo prime, and Alt-A mortgage loans; first or second lien loans secured by multifamily properties, mixed residential or other commercial properties, retail properties, office properties, or industrial properties; and asset-based securities (ABS), including commercial mortgage-backed securities, debt and equity tranches of collateralized debt obligations, and consumer and non-consumer ABS. The company has elected to be treated as a REIT for federal income tax purposes and would not be subject to income tax, if it distributes at least 90% of its REIT taxable income to its share holders. Chimera Inve stment Corporation was founded in 2007 and is based in New York, New York.

Advisors' Opinion:
  • [By John Maxfield]

    "Nepotism has never been unknown in American banking," Martin Mayer wrote in The Greatest-Ever Bank Robbery, his 1990 book about the savings-and-loan crisis. While Mayer was referring to American Continental, the notoriously corrupt holding company run into the ground by the infamous Charles Keating in the 1980s, his point rings true today in the case of Annaly Capital Management (NYSE: NLY  ) and its publicly traded portfolio company Chimera Investment (NYSE: CIM  ) .

  • [By Dan Caplinger]

    Berkshire isn't the only company where book value plays an important role. In the mortgage REIT realm, the value of the investment portfolio for a given mortgage REIT reduced by the REIT's outstanding debt, sometimes referred to as net asset value rather than book value, gives valuable information about its relative valuation. Industry leader Annaly Capital (NYSE: NLY  ) currently sports a price-to-book ratio of 0.96 based on its most recently provided figures, reflecting in part investor skepticism about whether the REIT's agency-issued mortgage-backed securities will hold their value once the Federal Reserve stops making extensive bond purchases as part of its quantitative easing program. By contrast, Annaly's non-agency-issued counterpart, Chimera Investment (NYSE: CIM  ) , sports a price-to-book ratio of nearly 1.1, indicating a significant premium to the REIT's stated net asset value that could be due to the fact that the Fed hasn't focused its efforts on the alternative securities that Chimera tends to choose for its portfolio.

No comments:

Post a Comment